A detailed history of Mai Capital Management transactions in Zoetis Inc. stock. As of the latest transaction made, Mai Capital Management holds 116,025 shares of ZTS stock, worth $20.7 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
116,025
Previous 116,562 0.46%
Holding current value
$20.7 Million
Previous $19.7 Million 1.98%
% of portfolio
0.2%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $78,154 - $96,031
-537 Reduced 0.46%
116,025 $20.1 Million
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $3.47 Million - $4.19 Million
20,937 Added 21.89%
116,562 $19.7 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $2.31 Million - $3.05 Million
15,237 Added 18.95%
95,625 $18.9 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $4.26 Million - $4.91 Million
25,460 Added 46.35%
80,388 $14 Million
Q2 2023

Aug 02, 2023

BUY
$160.94 - $186.23 $7.98 Million - $9.24 Million
49,593 Added 929.58%
54,928 $9.46 Million
Q1 2023

May 10, 2023

BUY
$145.48 - $175.02 $49,608 - $59,681
341 Added 6.83%
5,335 $887,000
Q4 2022

Feb 09, 2023

BUY
$131.14 - $157.47 $219,659 - $263,762
1,675 Added 50.47%
4,994 $732,000
Q3 2022

Nov 15, 2022

BUY
$148.29 - $182.55 $16,311 - $20,080
110 Added 3.43%
3,319 $492,000
Q2 2022

Jul 19, 2022

SELL
$155.97 - $200.09 $307,416 - $394,377
-1,971 Reduced 38.05%
3,209 $552,000
Q1 2022

May 10, 2022

SELL
$181.39 - $234.03 $328,315 - $423,594
-1,810 Reduced 25.89%
5,180 $977,000
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $432,316 - $551,370
2,232 Added 46.91%
6,990 $1.71 Million
Q3 2021

Nov 12, 2021

BUY
$189.29 - $209.69 $18,171 - $20,130
96 Added 2.06%
4,758 $924,000
Q2 2021

Jul 19, 2021

BUY
$155.9 - $187.99 $23,073 - $27,822
148 Added 3.28%
4,662 $869,000
Q1 2021

May 10, 2021

BUY
$144.0 - $169.39 $58,320 - $68,602
405 Added 9.86%
4,514 $711,000
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $57,958 - $64,335
369 Added 9.87%
4,109 $680,000
Q3 2020

Oct 26, 2020

SELL
$137.1 - $165.37 $96,107 - $115,924
-701 Reduced 15.78%
3,740 $618,000
Q2 2020

Jul 27, 2020

BUY
$111.92 - $142.53 $6,827 - $8,694
61 Added 1.39%
4,441 $609,000
Q1 2020

Apr 16, 2020

SELL
$92.66 - $144.94 $57,819 - $90,442
-624 Reduced 12.47%
4,380 $515,000
Q4 2019

Feb 03, 2020

BUY
$116.25 - $133.25 $1,395 - $1,599
12 Added 0.24%
5,004 $662,000
Q3 2019

Oct 29, 2019

SELL
$112.57 - $128.43 $13,846 - $15,796
-123 Reduced 2.4%
4,992 $622,000
Q2 2019

Aug 15, 2019

SELL
$97.98 - $114.28 $10,483 - $12,227
-107 Reduced 2.05%
5,115 $581,000
Q1 2019

Apr 29, 2019

SELL
$81.56 - $100.67 $11,173 - $13,791
-137 Reduced 2.56%
5,222 $526,000
Q4 2018

Jan 30, 2019

BUY
$79.28 - $95.27 $217,623 - $261,516
2,745 Added 105.01%
5,359 $458,000
Q3 2018

Oct 12, 2018

SELL
$83.5 - $93.23 $3,507 - $3,915
-42 Reduced 1.58%
2,614 $239,000
Q2 2018

Aug 16, 2018

SELL
$79.9 - $89.2 $9,987 - $11,150
-125 Reduced 4.49%
2,656 $226,000
Q1 2018

Apr 17, 2018

SELL
$71.51 - $84.69 $51,058 - $60,468
-714 Reduced 20.43%
2,781 $232,000
Q4 2017

Jan 30, 2018

BUY
$63.24 - $72.8 $18,529 - $21,330
293 Added 9.15%
3,495 $252,000
Q3 2017

Oct 12, 2017

BUY
$59.73 - $65.4 $191,255 - $209,410
3,202
3,202 $204,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mai Capital Management Portfolio

Follow Mai Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Mai Capital Management with notifications on news.